<DOC>
	<DOC>NCT00516139</DOC>
	<brief_summary>This study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy. This study will be carried out using an extended-release formulation of lamotrigine (LTG-XR) that will allow once-a-day dosing.</brief_summary>
	<brief_title>Lamotrigine Extended-Release In Elderly Patients With Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Inclusion criteria: Confident diagnosis of epilepsy Currently treated with one or two antiepileptic medications Able to complete a seizure diary Exclusion criteria: History of hypersensitivity to lamotrigine Progressive diseases that would interfere with the study objectives</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Epilepsy elderly seizure</keyword>
</DOC>